Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Interpace Biosciences Inc (IDXG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.0500 -0.1500    -4.69%
05/07 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US46062X3035 
S/N:  46062X303
  • Volume: 8,630
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 3.0000 - 3.2000
Interpace Biosciences 3.0500 -0.1500 -4.69%
Premarket Losers as of 9:05 am (3/16/2018)
Premarket Losers as of 9:05 am (3/16/2018) By Seeking Alpha - Mar 16, 2018

OSTK -14% on Q4 earnings.KNDI -9% on FY earnings.HIBB -7% on Q4 earnings.DELT -6%.IDXG -5% on Q4 earnings.TIF -5% on Q4 earnings. Now read: Healthy Spreads And International Expansion Helping...

Key events next week - healthcare
Key events next week - healthcare By Seeking Alpha - Jan 26, 2018

Healthcare investors have a full slate of events ahead next week:Sunday (1/28)(three days): Association of Cancer Executives Annual Meeting, Portland, OR.FDA action date for Roche's (OTCQX:RHHBY)...

Premarket Gainers as of 9:05 am
Premarket Gainers as of 9:05 am By Seeking Alpha - Dec 27, 2017

WATT +89% on FCC certification.NVFY +16% on the launch of design of a digital community based on block chain technology.DFFN +15% on announcement that a Phase 3 clinical trial with newly-diagnosed...

Stocks to watch next week
Stocks to watch next week By Seeking Alpha - Dec 09, 2017

Subscription notice: You can automatically receive Stocks to Watch every week by following the SA Stocks to Watch account and setting email alerts on. Key events are scheduled for the companies...

NY OKs Interpace's TERT service; shares up 8% premarket
NY OKs Interpace's TERT service; shares up 8% premarket By Seeking Alpha - Nov 16, 2017

Interpace Diagnostics (NASDAQ:IDXG) is up 8% premarket on average volume in response to its announcement that the New York State Department of Health has approved its TERT service offering that can be...

Premarket Gainers as of 9:05 am
Premarket Gainers as of 9:05 am By Seeking Alpha - Oct 18, 2017

SSKN +38% on deal with aesthetic medical market-focused group purchasing organization. SPPI +34% as poziotinib shows encouraging effect in treatment-resistant lung cancer patients in mid-stage...

Premarket Gainers as of 9:05 am
Premarket Gainers as of 9:05 am By Seeking Alpha - Oct 11, 2017

RGSE +41%. IDXG +19% on 40% reimbursement boost for ThyGenX. CASI +19%. HMNY +19%. ATHX +14% on entering into a manufacturing services agreement with Nikon CeLL innovation. ANY...

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IDXG Comments

Write your thoughts about Interpace Biosciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Zoran Labus
Zoran Labus Mar 25, 2021 11:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
Zoran Labus
Zoran Labus Mar 25, 2021 11:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
Paco Bv
Pacob Oct 26, 2020 6:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Interpace Biosciences Announces Results of Seminal Clinical Validation Study for Thyroid Assays  -->  https://ir.interpace.com/press-releases/detail/184/interpace-biosciences-announces-results-of-seminal-clinical  --> ThyGeNEXT® + ThyraMIR® combination testing yield the highest positive predictive value (PPV) and similar negative predictive value (NPV) in comparison to other marketed tests for the same indication
Paco Bv
Pacob Oct 14, 2020 2:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Last call to visit the $ummit
Paco Bv
Pacob Oct 14, 2020 2:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Year to date Net Revenue was $14.6 million, a 19% increase as compared to the same period of 2019. Second quarter Net Revenue was $5.4 million   -->  https://ir.interpace.com/press-releases/detail/183/interpace-biosciences-announces-second-quarter-2020
Paco Bv
Pacob Oct 14, 2020 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ThyGenX® and ThyraMIR® Data from Clinical Experience Study to be Featured at ATA Product Expo
Paco Bv
Pacob Oct 14, 2020 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.evicore.com/-/media/files/evicore/clinical-guidelines/solution/lab-management/healthplan/test-specific-guidelines/thyramir_and_thygenx_2020_v2.pdf
Paco Bv
Pacob Oct 14, 2020 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://onlinelibrary.wiley.com/doi/epdf/10.1002/dc.24564     --->  Huge  UP
Artemis Loulas
Artemis Loulas Aug 24, 2020 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any opinion....
Jonathan Medina
Jonathan Medina Sep 10, 2018 11:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how big do you think this stock can get?
Thomas Wilson
Thomas Wilson May 29, 2018 11:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where’s this rebound
Kevin White
Kevin White Mar 14, 2018 5:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Has been in a slump for a while bit the pull back is awesome. I expect nothing but tripple to quadrupole gains once it starts moving in the right direction.
Ryan Stupp
Ryan Stupp Sep 06, 2017 9:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm loading up another 10k shares. Setting a limit buy at 1.70 & 1.71, 5k each... Incase I miss the 1.70. In my opinion this stock will be seeing over $2.00 today, this little dip will spark a huge buy and end the day $1.90-$2.10
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email